From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.

[1]  J. Cianfrogna,et al.  Evaluation of Cerebrospinal Fluid Concentration and Plasma Free Concentration As a Surrogate Measurement for Brain Free Concentration , 2006, Drug Metabolism and Disposition.

[2]  D. Donati,et al.  From pyrroles to pyrrolo[1,2-a]pyrazinones: a new class of mGluR1 antagonists. , 2006, Bioorganic & medicinal chemistry letters.

[3]  P. Usherwood,et al.  The effects of conformational constraints and steric bulk in the amino acid moiety of philanthotoxins on AMPAR antagonism. , 2005, Journal of medicinal chemistry.

[4]  Fabio Maria Sabbatini,et al.  Metabotropic glutamate receptors: potential therapeutic applications of recently disclosed new chemical entities , 2004 .

[5]  A. Capelli,et al.  3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I. , 2004, Farmaco.

[6]  D. Donati,et al.  3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part II, A solid-phase approach. , 2004, Farmaco.

[7]  G. Tarzia,et al.  2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: an exploration of the role of the pyrrolic scaffold. , 2003, Farmaco.

[8]  F. Bordi,et al.  2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: further characterization of 3,5-dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester and structure-activity relationships. , 2003, Bioorganic & medicinal chemistry letters.

[9]  J. Pin,et al.  Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity. , 2002, Journal of medicinal chemistry.

[10]  J. Pin,et al.  The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. , 2002, Current drug targets. CNS and neurological disorders.

[11]  G. Costantino,et al.  Pharmacophore models of group I and group II metabotropic glutamate receptor agonists. Analysis of conformational, steric, and topological parameters affecting potency and selectivity. , 1999, Journal of medicinal chemistry.

[12]  A. Reggiani,et al.  Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. , 1999, The Journal of pharmacology and experimental therapeutics.

[13]  C. Parsons,et al.  Glutamate in CNS disorders as a target for drug development: an update. , 1998, Drug news & perspectives.

[14]  T. Knöpfel,et al.  Metabotropic glutamate receptors: novel targets for drug development. , 1995, Journal of medicinal chemistry.

[15]  G. Collingridge,et al.  The NMDA Receptor , 1995 .

[16]  Yun-Qing He,et al.  Reduction with Metal Borohydride-Transition Metal Salt System. I. Reduction of Aromatic Nitro Compounds with Potassium Borohydride-Copper(I) Chloride , 1989 .

[17]  A. Monge,et al.  Selective thromboxane synthetase inhibitors and antihypertensive agents. New derivatives of 4-hydrazino-5H-pyridazino[4,5-b]indole, 4-hydrazinopyridazino[4,5-a]indole, and related compounds. , 1987, Journal of medicinal chemistry.

[18]  M. Alexander,et al.  Principles of Neural Science , 1981 .

[19]  C. Chiamulera,et al.  Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists. , 2003, Bioorganic & medicinal chemistry.

[20]  J. Pin,et al.  Three‐dimensional model of the extracellular domain of the type 4a metabotropic glutamate receptor: New insights into the activation process , 2000, Protein science : a publication of the Protein Society.

[21]  B. Meldrum.  Excitatory amino acid antagonists , 1991 .

[22]  J. Wroblewski,et al.  Modulation of glutamate receptors: molecular mechanisms and functional implications. , 1989, Annual review of pharmacology and toxicology.

[23]  R. Abramovitch.  881. Tryptamines, carbolines, and related compounds. Part III. 1-Methyl- and 1 : N-dimethyl-tryptamines , 1956 .

[24]  R. Abramovitch,et al.  880. Tryptamines, carbolines, and related compounds. Part II. A convenient synthesis of tryptamines and β-carbolines , 1956 .